The present invention is directed to the use of a composition comprisinga) N-(5-chlorosalicyloyl)-8-aminocaprylic acid, wherein N-(5-chlorosalicyloyl)-8-aminocaprylic acid comprises at least about 96% by weight of the disodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid andb) salmon calcitonin, for the preparation of a medicament for orally administering salmon calcitonin to an animal.